{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:04:53Z","timestamp":1790629493806,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cgh.2026.07.028","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:36:25Z","timestamp":1787787385000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low Metabolic Dysfunction\u2013Associated Steatotic Liver Disease Awareness and Missed Screening Opportunities: Results From a United Kingdom Population and Clinician Survey"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1808-574X","authenticated-orcid":false,"given":"Damien","family":"Leith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruairi W.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.07.028_bib1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep4.1831","article-title":"Community socioeconomic deprivation predicts nonalcoholic steatohepatitis","volume":"6","author":"Giammarino","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2026.07.028_bib3","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/hep.32207","article-title":"High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population","volume":"75","author":"Vilar-Gomez","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.07.028_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2026.07.028_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s43856-025-00871-1","article-title":"The importance of patient engagement in the multimodal treatment of MASLD","volume":"5","author":"Boeckmans","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.cgh.2026.07.028_bib7","author":"Smith"},{"key":"10.1016\/j.cgh.2026.07.028_bib8","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/MCG.0000000000000075","article-title":"Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk","volume":"49","author":"Wieland","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2026.07.028_bib9","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s10620-019-05700-9","article-title":"Awareness of nonalcoholic fatty liver disease is increasing but remains very low in a representative US cohort","volume":"65","author":"Singh","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2026.07.028_bib10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hep4.1765","article-title":"Poor awareness of liver disease among adults with NAFLD in the United States","volume":"5","author":"Alqahtani","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2026.07.028_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10620-018-5389-5","article-title":"Awareness and knowledge of nonalcoholic fatty liver disease among office employees in Beijing, China","volume":"64","author":"Zhang","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2026.07.028_bib12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1186\/s12889-020-09249-5","article-title":"Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?","volume":"20","author":"Alemany-Pag\u00e8s","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cgh.2026.07.028_bib13","doi-asserted-by":"crossref","first-page":"e0704","DOI":"10.1097\/HC9.0000000000000704","article-title":"Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States","volume":"9","author":"Lazarus","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2026.07.028_bib14","doi-asserted-by":"crossref","first-page":"e1456","DOI":"10.1016\/j.cgh.2021.06.048","article-title":"A Global Survey of Physicians knowledge about nonalcoholic fatty liver disease","volume":"20","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib15","article-title":"Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. cities","volume":"31","year":"2026","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib16","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s11606-021-07197-3","article-title":"Nonalcoholic fatty liver disease underdiagnosis in primary care: what are we missing?","volume":"37","author":"Nielsen","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cgh.2026.07.028_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14799","article-title":"An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care","volume":"39","author":"Gracen","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/j.cgh.2026.07.028_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/gutjnl-2023-330771","article-title":"Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm","volume":"73","author":"Brennan","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.07.028_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013351","article-title":"Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data sets","volume":"7","author":"McKinstry","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cgh.2026.07.028_bib34","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1177\/0962280218784726","article-title":"Sample size for binary logistic prediction models: Beyond events per variable criteria","volume":"28","author":"van Smeden","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cgh.2026.07.028_bib25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ueg2.12445","article-title":"A global survey of health care workers\u2019 awareness of non-alcoholic fatty liver disease: the AwareNASH survey","volume":"11","author":"Driessen","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2026.07.028_bib26","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/liv.15951","article-title":"We must address the MASLD awareness gap, improve educational quality and prepare for the digitally quantified self","volume":"44","author":"Kopka","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.07.028_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173499","article-title":"Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States","volume":"12","author":"Le","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.07.028_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic Fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101535","article-title":"The myth of the stigma of fatty liver: what does the evidence show?","volume":"29","author":"Ram\u00edrez-Mej\u00eda","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib29","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jhep.2022.08.027","article-title":"Mafld 2022: an ELPA\/ALPA\/EASO-ECPO joint statement on disease stigma","volume":"77","author":"Shiha","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2023.11.004","article-title":"Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.07.028_bib31","article-title":"National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022","volume":"5","author":"Li","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2026.07.028_bib32","article-title":"Barriers to care linkage and educational impact on unnecessary MASLD referrals","volume":"11","author":"Lee","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cgh.2026.07.028_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-086594","article-title":"iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, Scotland","volume":"14","author":"Lin","year":"2024","journal-title":"BMJ Open"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526005690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526005690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:30:14Z","timestamp":1790627414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526005690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S1542356526005690"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.07.028","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Metabolic Dysfunction\u2013Associated Steatotic Liver Disease Awareness and Missed Screening Opportunities: Results From a United Kingdom Population and Clinician Survey","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}